What restriction applies to mixing the Eisai Ltd eribulin mesylate 0.44 mg/ml solution for injection product with other medicines in the absence of compatibility studies?

In the absence of compatibility studies, the Eisai Ltd eribulin mesylate 0.44 mg/ml solution for injection product must not be mixed with other medicinal products except those mentioned in section 6.6 of its SmPC.